AnPac Bio-Medical Science Co., Ltd. announced the resignation of Yuyang Cui as the Co-Chief Executive Officer, effective from November 7, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4746 USD | +13.41% | +12.30% | -46.67% |
04-22 | Fresh2 Group Receives Nasdaq Notice of Non-Compliance | MT |
03-21 | ADRs Edge Higher; Lufax Climbs Almost 46% | DJ |
1st Jan change | Capi. | |
---|---|---|
-46.67% | 10.55M | |
-31.90% | 9.3B | |
-6.25% | 3.1B | |
-13.96% | 2.17B | |
-16.83% | 1.75B | |
+72.82% | 1.5B | |
+29.17% | 807M | |
-2.62% | 759M | |
-26.33% | 532M | |
+4.97% | 313M |
- Stock Market
- Equities
- FRES Stock
- News Fresh2 Group Limited
- AnPac Bio-Medical Science Co., Ltd. Announces Resignation of Yuyang Cui as Co-Chief Executive Officer